SELEX-derived aptamers of the duck hepatitis B virus RNA encapsidation signal distinguish critical and non-critical residues for productive initiation of reverse transcription

Nucleic Acids Research

Volumn 32, Issue 14, 2004, Pages 4377-4389

  Hu, Kanghong ^a,b   Beck, Jürgen ^a   Nassal, Michael ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; CAPSID PROTEIN; RNA BINDING PROTEIN; RNA DIRECTED DNA POLYMERASE; VIRUS RNA; OLIGORIBONUCLEOTIDE;

AMINO ACID SEQUENCE; ARTICLE; BASE PAIRING; CONSENSUS SEQUENCE; CONSERVATION GENETICS; CONTROLLED STUDY; DNA FLANKING REGION; GENE LIBRARY; GENETIC VARIABILITY; HEPATITIS B VIRUS; IN VITRO STUDY; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN RNA BINDING; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VIRAL GENETICS; VIRUS CAPSID; VIRUS MUTANT; VIRUS REPLICATION; VIRUS TYPING; ANIMAL; CHEMISTRY; CONFORMATION; DIRECTED MOLECULAR EVOLUTION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PHYSIOLOGY; REGULATORY RNA SEQUENCE; TUMOR CELL LINE; VIRUS GENOME; VIRUS NUCLEOCAPSID;

ANAS SP.; AVES; DUCK HEPATITIS B VIRUS; HEPATITIS B VIRUS; MAMMALIA;

ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; DIRECTED MOLECULAR EVOLUTION; GENOME, VIRAL; HEPATITIS B VIRUS, DUCK; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; NUCLEOCAPSID; OLIGORIBONUCLEOTIDES; REGULATORY SEQUENCES, RIBONUCLEIC ACID; RNA, VIRAL; RNA-DIRECTED DNA POLYMERASE; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 4043152931     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkh772     Document Type: Article

References (49)

1. Blumberg,B.S. (1997) Hepatitis B virus, the vaccine, and the control of primary cancer of the liver. Proc. Natl Acad. Sci. USA, 94, 7121-7125.
2. Nassal,M. (1999) Hepatitis B virus replication: novel roles for virus-host interactions. Intervirology, 42, 100-116.
3. Nassal,M. (2000) Macromolecular interactions in hepatitis B virus replication and particle assembly. In Cann,A.J. (ed.), DNA Virus Replication. Oxford University Press, Oxford, UK, Vol. 26, pp. 1-40.
4. Ganem,D. and Schneider,R. (2001) Hepadnaviridae: the viruses and their replication. In Fields,B.N. et al. (eds) Fields Virology, 4th edn Lippincott Williams & Wilkins, Philadelphia, PA
5. Eickbush,T.H. (1994) Origin and evolutionary relationships of retroelements. In Morse,S.S. (ed.), The Evolutionary Biology of Viruses. Raven Press, New York, NY, pp. 121-160.
6. Das,K., Xiong,X., Yang,H., Westland,C.E., Gibbs,C.S., Sarafianos,S.G. and Arnold,E. (2001) Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC). J. Virol., 75, 4771-4779.
7. Beck,J., Vogel,M. and Nassal,M. (2002) dNTP versus NTP discrimination by phenylalanine 451 in duck hepatitis B virus P protein indicates a common structure of the dNTP-binding pocket with other reverse transcriptases. Nucleic Acids Res., 30, 1679-1687.
8. Wang,G.H. and Seeger,C. (1992) The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell, 71, 663-670.
9. Knaus,T. and Nassal,M. (1993) The encapsidation signal on the hepatitis B virus RNA pregenome forms a stem-loop structure that is critical for its function. Nucleic Acids Res., 21, 3967-3975.
10. Pollack,J.R. and Ganem,D. (1994) Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis. J. Virol., 68, 5579-5587.
11. Weber,M., Bronsema,V., Bartos,H., Bosserhoff,A., Bartenschlager,R. and Schaller,H. (1994) Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription. J. Virol., 68, 2994-2999.
12. Hu,J. and Seeger,C. (1996) Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc. Natl Acad. Sci. USA, 93, 1060-1064.
13. Hu,J., Toft,D.O. and Seeger,C. (1997) Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J., 16, 59-68.
14. Hu,J. and Anselmo,D. (2000) In vitro reconstitution of a functional duck hepatitis B virus reverse transcriptase: posttranslational activation by Hsp90. J. Virol., 74, 11447-11455.
15. Beck,J. and Nassal,M. (2001) Reconstitution of a functional duck hepatitis B virus replication initiation complex from separate reverse transcriptase domains expressed in Escherichia coli. J. Virol., 75, 7410-7419.
16. Beck,J. and Nassal,M. (2003) Efficient Hsp90-independent in vitro activation by Hsc70 and Hsp40 of duck hepatits B virus reverse transcriptase, an assumed Hsp90 client protein. J. Biol. Chem., 278, 36128-36138.
17. Hu,J., Toft,D., Anselmo,D. and Wang,X. (2002) In vitro reconstitution of functional hepadnavirus reverse transcriptase with cellular chaperone proteins. J. Virol., 76, 269-279.
18. Beck,J. and Nassal,M. (1997) Sequence- and structure-specific determinants in the interaction between the RNA encapsidation signal and reverse transcriptase of avian hepatitis B viruses. J. Virol., 71, 4971-4980.
19. Schaaf,S.G., Beck,J. and Nassal,M. (1999) A small 2′-OH- and base-dependent recognition element downstream of the initiation site in the RNA encapsidation signal is essential for hepatitis B virus replication initiation. J. Biol. Chem., 274, 37787-37794.
20. Beck,J. and Nassal,M. (1998) Formation of a functional hepatitis B virus replication initiation complex involves a major structural alteration in the RNA template. Mol. Cell. Biol., 18, 6265-6272.
21. Flodell,S., Schleucher,J., Cromsigt,J., Ippel,H., Kidd-Ljunggren,K. and Wijmenga,S. (2002) The apical stem-loop of the hepatitis B virus encapsidation signal folds into a stable tri-loop with two underlying pyrimidine bulges. Nucleic Acids Res., 30, 4803-4811.
22. Sprengel,R., Kaleta,E.F. and Will,H. (1988) Isolation and characterization of a hepatitis B virus endemic in herons. J. Virol., 62, 3832-3839.
23. Beck,J., Bartos,H. and Nassal,M. (1997) Experimental confirmation of a hepatitis B virus (HBV) epsilon-like bulge-and-loop structure in avian HBV RNA encapsidation signals. Virology, 227, 500-504.
24. Hartl,F.U. and Hayer-Hartl,M. (2002) Molecular chaperones in the cytosol: from nascent chain to folded protein. Science, 295, 1852-1858.
25. Tuerk,C. and Gold,L. (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science, 249, 505-510.
26. Ellington,A.D. and Szostak,J.W. (1990) In vitro selection of RNA molecules that bind specific ligands. Nature, 346, 818-822.
27. Wilson,D.S. and Szostak,J.W. (1999) In vitro selection of functional nucleic acids. Annu. Rev. Biochem., 68, 611-647.
28. Brody,E.N. and Gold,L. (2000) Aptamers as therapeutic and diagnostic agents. J. Biotechnol., 74, 5-13.
29. Beck,J. and Nassal,M. (1996) A sensitive procedure for mapping the boundaries of RNA elements binding in vitro translated proteins defines a minimal hepatitis B virus encapsidation signal. Nucleic Acids Res., 24, 4364-4366.
30. Protzer,U., Nassal,M., Chiang,P.W., Kirschfink,M. and Schaller,H. (1999) Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection. Proc. Natl Acad. Sci. USA, 96, 10818-10823.
31. Obert,S., Zachmann-Brand,B., Deindl,E., Tucker,W., Bartenschlager,R. and Schaller,H. (1996) A splice hepadnavirus RNA that is essential for virus replication. EMBO J., 15, 2565-2574.
32. Ostrow,K.M. and Loeb,D.D. (2002) Characterization of the cis-acting contributions to avian hepadnavirus RNA encapsidation. J. Virol., 76, 9087-9095.
33. Calvert,J. and Summers,J. (1994) Two regions of an avian hepadnavirus RNA pregenome are required in cis for encapsidation. J. Virol., 68, 2084-2090.
34. Birnbaum,F. and Nassal,M. (1990) Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J. Virol., 64, 3319-3330.
35. Cox,J.C., Hayhurst,A., Hesselberth,J., Bayer,T.S., Georgiou,G. and Ellington,A.D. (2002) Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer. Nucleic Acids Res., 30, e108.
36. Morris,K.N., Jensen,K.B., Julin,C.M., Weil,M. and Gold,L. (1998) High affinity ligands from in vitro selection: complex targets. Proc. Natl Acad. Sci. USA, 95, 2902-2907.
37. Blank,M., Weinschenk,T., Priemer,M. and Schluesener,H. (2001) Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. Selective targeting of endothelial regulatory protein pigpen. J. Biol. Chem., 276, 16464-16468.
38. Cerchia,L., Hamm,J., Libri,D., Tavitian,B. and de Franciscis,V. (2002) Nucleic acid aptamers in cancer medicine. FEBS Lett., 528, 12-16.
39. Famulok,M., Mayer,G. and Blind,M. (2000) Nucleic acid aptamers-from selection in vitro to applications in vivo. Acc. Chem. Res., 33, 591-599.
40. Gold,L. (2002) RNA as the catalyst for drug screening. Nat. Biotechnol., 20, 671-672.
41. Daniels,D.A., Chen,H., Hicke,B.J., Swiderek,K.M. and Gold,L. (2003) A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment. Proc. Natl Acad. Sci. USA, 100, 15416-15421.
42. Thanbichler,M. and Böck,A. (2001) Functional analysis of prokaryotic SELB proteins. Biofactors, 14, 53-59.
43. Klug,S.J., Hüttenhofer,A., Kromayer,M. and Famulok,M. (1997) In vitro and in vivo characterization of novel mRNA motifs that bind special elongation factor SelB. Proc. Natl Acad. Sci. USA, 94, 6676-6681.
44. Klug,S.J., Hüttenhofer,A. and Famulok,M. (1999) In vitro selection of RNA aptamers that bind special elongation factor SelB, a protein with multiple RNA-binding sites, reveals one major interaction domain at the carboxyl terminus. RNA, 5, 1180-1190.
45. Lim,F. and Peabody,D.S. (2002) RNA recognition site of PP7 coat protein. Nucleic Acids Res., 30, 4138-4144.
46. Burke,D.H., Scates,L., Andrews,K. and Gold,L. (1996) Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase. J. Mol. Biol., 264, 650-666.
47. Jaeger,J., Restle,T. and Steitz,T.A. (1998) The structure of HIV-1 reverse transcriptase complexed with an RNA pseudoknot inhibitor. EMBO J., 17, 4535-4542.
48. Kensch,O., Connolly,B.A., Steinhoff,H.J., McGregor,A., Goody,R.S. and Restle,T. (2000) HIV-1 reverse transcriptase-pseudoknot RNA aptamer interaction has a binding-affinity in the low picomolar range coupled with high specificity. J. Biol. Chem., 275, 18271-18278.
49. Chaloin,L., Lehmann,M.J., Sczakiel,G. and Restle,T. (2002) Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1. Nucleic Acids Res., 30, 4001-4008.